Debt to Equity breakdown for PfizerDebt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been barrowing aggressive to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging barrowing against the capital invested by the owners.
Pfizer Debt to Equity Assessment
According to company disclosure Pfizer Inc has Debt to Equity of 0.49 times. This is 16.95% lower than that of Healthcare sector, and 22.22% lower than that of Drug Manufacturers - Major industry, The Debt to Equity for all stocks is 19.51% lower than the firm.
Filter other Stocks by Debt to Equity
Debt to Equity ComparisonPfizer is regarded third in debt to equity category among related companies.
Follow Pfizer Debt to Equity with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Other Pfizer Fundamentals